#USA #San Diego #Aortic Stenosis #CardioCare #egnite Health

Increased Risks in Moderate Aortic Stenosis Patients

A recent comprehensive study conducted by egnite Health has unveiled concerning findings regarding moderate aortic stenosis (AS), a common heart condition affecting millions. This groundbreaking research, which encompassed over 53,000 patients from 48 institutions across the U.S., highlighted significant mortality risks associated with specific at-risk features in patients diagnosed with moderate AS.

According to the analysis published in the Journal of the American College of Cardiology (JACC) during the TCT 2026 conference in San Diego, the study found that nearly 78.7% of patients with moderate AS exhibited at least one feature linked to increased risk. Astonishingly, these patients experienced twice the mortality and hospitalization rates due to heart failure compared to their counterparts lacking such at-risk traits.

Key Findings of the Study

The findings enumerated in the study depict a stark reality for those battling moderate aortic stenosis:

• - Out of the 53,994 patients analyzed, moderate AS cases surpassed severe cases, nearly twice as many (35,343 moderate cases versus 18,651 severe).
• - 78.7% of moderate AS patients presented at least one at-risk characteristic, such as valve-related symptoms, low left ventricular ejection fraction, or elevated natriuretic peptides.
• - The mortality rate stood at 20.1% for those showing at-risk features, while it dropped to 9.0% for those without.
• - Similarly, hospitalization due to heart failure averaged 44.6% among at-risk patients, juxtaposed with just 21.9% in those who weren't at risk.

Remarkably, most adverse events occurred while patients were still categorized as having moderate AS. In fact, reports indicated that 86% of hospitalizations and 90% of deaths happened without any documented progression to severe AS.

Implications for Clinical Practices

Amid these striking statistics, Dr. Philippe Généreux of the Atlantic Health Morristown Medical Center announced the launch of ACTIVATE AS, a prospective multicenter study designed to monitor patients with moderate AS meticulously. This initiative aims to follow approximately 700 patients using the CardioCare® platform to ensure rigorous documentation of their conditions every six months.

Dr. Généreux anticipates that through diligent assessments, monitoring intervals for patients can be refined, setting the stage for improved outcomes in moderate AS. This ongoing surveillance will not only enhance understanding but may also redirect treatment pathways crucial for managing patients more effectively.

Future Perspectives

The investigation further emphasizes the current American College of Cardiology (ACC) and American Heart Association (AHA) guidelines, which recommend echocardiographic evaluations biennially for individuals with moderate AS. Notably, it was found that only 20% to 23% of moderate AS patients underwent valve replacements within two years, a stark contrast to 50.1% of individuals classified with severe AS.

The egnite study, renowned for being one of the largest examinations of moderate AS outcomes, utilized de-identified data from the egnite Registry, which encompasses nearly 15 million patients and over 6.5 million echocardiograms.

As the medical community grapples with these findings, it is clear that future research and clinical practices need to evolve accordingly to mitigate the risks associated with moderate aortic stenosis. With noteworthy findings at hand, the imperative to redefine monitoring strategies for patients exhibiting at-risk features has never been more pressing. By effectively identifying and managing these patients, healthcare practitioners may ultimately improve survival rates and enhance the quality of life for individuals diagnosed with this condition.